Subsequent work in murine knockout models has confirmed that SCN9A channelopathies not only contribute to increased baseline and inflammatory nociceptive thresholds, but also attenuate select chemical sensitivities and mediate itch response to specific pruritogens (Hoffmann et al., 2018; Shields et al., 2018). Here, SCN9A is linked to channelopathy.